Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GM food debate

R A Fisken

    Lancet (London, England)
    |November 24, 1999
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Biallylamicol, a new amebicide. II. Absorption, distribution in tissues, and excretion.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Biallylamicol, a new amebicide. III. Toxicity studies.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Experimental toxicological studies on oleandomycin.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Laboratory studies on amopyroquin (propoquin), an antimalarial compound.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    The effect of streptomycin on experimental syphilis infection of rabbits.

    American journal of syphilis, gonorrhea, and venereal diseases·2010
    Same author

    A toxicologic study of two histamine antagonists of the benzhydryl alkamine ether group.

    The Journal of pharmacology and experimental therapeutics·2010
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    Same journal

    Dual mobility total hip replacement in fractures: stability promotes patient confidence.

    Lancet (London, England)·2026
    Same journal

    Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

    Lancet (London, England)·2026
    See all related articles